T he authors have prospectively assessed stone recurrence in 110 participants using body mass index (BMI), fasting serum leptin and adiponectin, and proportion of visceral adipose tissue (%VAT) obtained on axial computed tomography (CT) scans. 1 Since BMI does not differentiate between peripheral and central obesity, the authors used elevated %VAT as an indicator for central obesity. While BMI and obesometric serum hormones did not correlate with recurrence, elevated %VAT was independently predictive of urolithiasis recurrence among initial stone formers (hazard ratio [HR] 4.53), but not among recurrent stone formers. 1 This is a very nice prospective study providing evidence for central obesity (elevated %VAT) correlating with stone recurrence. In addition to central obesity, metabolic syndrome traits also include raised triglycerides, reduced highdensity lipoprotein (HDL) cholesterol, raised blood pressure, and raised fasting plasma glucose. 2 Previous studies have shown that patients with three or more metabolic syndrome traits were associated with higher prevalence of urolithiasis. 2 Furthermore, patients with metabolic syndrome have been shown to have significantly higher stone recurrence post-percutaneous nephrolithotomy when compared with controls (41.9% vs. 18.9%; p=0.003). 3 In addition to the explanations provided by the authors for the lack of correlation of elevated %VAT with stone recurrence in recurrent stone formers, I would like to propose these two hypotheses. Although the authors excluded patients with residual stone burden, it is possible that recurrent stone formers may have had clinically insignificant residual fragments that contributed to stone recurrence rather than stone recurrence being attributed solely to the elevated %VAT and metabolic syndrome. In addition, as the authors mention, stone analyses and metabolic stone workup were not available for the study population. It is possible that recurrent stone formers may have had other metabolic abnormalities, such as primary hyperparathyroidism and distal renal tubular acidosis, unrelated to the elevated %VAT and metabolic syndrome. These may have contributed to the recurrence of stones rather than obesometric parameters, such as elevated % VAT.
What does this all mean? As the body of knowledge regarding metabolic syndrome correlating with urolithiasis grows, are we going to screen patients presenting with urolithiasis for metabolic syndrome traits by measuring waist circumference, waist-to-hip ratio, and %VAT? I don't think it is feasible for the practicing urologist to invest in such meticulous measurements of central obesity to determine how many metabolic syndrome traits each patient has. However, the lifestyle modification interventions that we advise our patients based on the latest Canadian Urological Association guideline (smoking cessation, increasing exercise, increasing hydration, and reducing intake of salt and animal protein) will not only reduce risk of stone recurrence, but have also been shown to be effective in resolving metabolic syndrome and reducing severity of its related abnormalities. 4-7 Therefore, we can exercise our CanMEDS health advocate roles and advise urolithiasis patients with central obesity to follow these lifestyle modifications.
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